Palbociclib in metastatic breast cancer: current evidence and real-life data

The purpose of this review is to summarize the background and latest evidence for the use of palbociclib, an oral, first-in-class, highly selective cyclin-dependent kinase 4/6 inhibitor, in advanced breast cancer, with a focus on some of the unanswered questions about the performance of this agent i...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Drugs Context
Asıl Yazarlar: Serra, Francesco, Lapidari, Pietro, Quaquarini, Erica, Tagliaferri, Barbara, Sottotetti, Federico, Palumbo, Raffaella
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioExcel Publishing Ltd 2019
Konular:
Review
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6668507/
https://ncbi.nlm.nih.gov/pubmed/31391852
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7573/dic.212579
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller